Skip to Main Content

A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1042 in Subjects With Malignant Solid Tumors

Conditions

Phase I

Phase I

What is the purpose of this trial?

To evaluate the safety of GEN1042 in patients with malignant solid tumors.

  • Trial with
    Genmab, Inc.
  • Start Date
    10/07/2020
  • End Date
    11/30/2020
Trial Image

For more information about this study, contact:

Ingrid Palma

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    10/09/2020
  • Study HIC
    #2000027214